Gynecology/Electrosurgery/Urology was Utah Medical Products’s largest region in fiscal 2025, bringing in $19.72M of $28.74M (69%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gynecology/Electrosurgery/Urology | $21.84M | $11.99M | $20.71M | $19.72M | ||||||
| Blood Pressure Monitoring & Accessories | $6.51M | $16.47M | $9.07M | $3.43M | ||||||
| Obstetrics | $4.66M | $4.59M | $4.26M | $4.00M | ||||||
| Neonatal | $7.57M | $6.86M | $1.52M | $1.59M | ||||||
| Total | $40.58M | $39.92M | $35.56M | $28.74M |
Utah Medical Products brought in $28.74M from its four regions in fiscal 2025, the year ended December 31, 2025. That was down 19.2% from $35.56M in fiscal 2024. Gynecology/Electrosurgery/Urology was the largest at $19.72M (68.6%), ahead of Obstetrics at $4.00M (13.9%) and Blood Pressure Monitoring & Accessories at $3.43M (11.9%). The remaining region, Neonatal, brought in $1.59M.
Compared with fiscal 2024, Neonatal grew fastest, up 4.5% to $1.59M, while Blood Pressure Monitoring & Accessories fell the most, down 62.2% to $3.43M. From fiscal 2022 to 2025, combined revenue from these regions fell from $40.58M to $28.74M, a compound annual decline of 10.9%. Gynecology/Electrosurgery/Urology's share of the total rose from 53.8% to 68.6%.
Ous was Utah Medical Products’s largest region in fiscal 2025, bringing in $15.76M of $22.55M (70%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ous | $20.31M | $11.99M | $3.72M | $15.76M | ||||||
| Global | $7.57M | $16.47M | $20.71M | $6.79M | ||||||
| Total | $27.88M | $28.46M | $24.43M | $22.55M |
Utah Medical Products brought in $22.55M from its two regions in fiscal 2025, the year ended December 31, 2025. That is less than the $28.74M it reports by geography, so these regions do not cover all of its revenue. Ous was the largest at $15.76M (69.9%), ahead of Global at $6.79M (30.1%).
Compared with fiscal 2024, Ous grew 323.1% to $15.76M, while Global fell 67.2% to $6.79M.
Utah Medical Products (UTMD) reports its revenue by geography. In fiscal 2025, Gynecology/Electrosurgery/Urology was its largest region, bringing in $19.72M (68.6% of the total), followed by Obstetrics at $4.00M (13.9%).
Gynecology/Electrosurgery/Urology was Utah Medical Products' largest region in fiscal 2025, bringing in $19.72M, or 68.6% of the $28.74M total across its four regions.
Among Utah Medical Products' regions that make up at least 2% of revenue, Neonatal grew fastest in fiscal 2025, up 4.5% from $1.52M to $1.59M.
Every figure comes from Utah Medical Products' annual financial filings, as reported. Each line keeps the name Utah Medical Products gives it, and years follow its fiscal calendar.
Utah Medical Products' revenue by geography goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.